Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?

And here is something we hope to make a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Labopharm hired Jeffrey Dayno as chief medical officer and so he will head clinical activities for drug development programs and oversee medical affairs. Dayno previously worked at Cephalon, where he was vp of medical services, and at Merck, where he was senior director of medical services in the US medical & scientific affairs division.

Silence Therapeutics promoted Jorg Kaufmann to vp of research;
ThermoGenesis added David Carter to its board;
WuXi PharmTech named Hao Zhou as cfo;
Cempra Pharmaceuticals named Mark Hahn as executive vp and cfo;
Unilife added Mary Kate Wold to its board;
Qualitest Pharma added Ron Johnston to its board;
Algorithme Pharma named Chris Perkin as ceo and president;
Epsilon hired Abe Gorelick as vp & general mgr in healthcare services;
BioNanomatrix added David Barker to its board;
Fate Therapeutics hired Tom Novak as vp of research and drug discovery;
ClinTec named Austin Clarke as director of global clinical resourcing;
IMARC Research promoted Brandy Smith to chief of clinical operations;
N30 Pharma added Howard Furst to its board;
SCH Pharma hired Diane Sharp as managing director;
Novasep hired Stephen Stefano as ceo and president;
GlaxoSmithKline named Patrick Vallance as sr vp, medicines discovery & development.

Ladder shot thx to Robert CB on Flickr Creative Commons